Scientists at UCSF have found that endometriosis—a painful chronic disease affecting 10% of women that often goes undiagnosed—often occurs alongside conditions like cancer, Crohn’s disease, and migraine.
ORANGE, Calif., July 30, 2025 /PRNewswire/ — Gnosis, a Southern California-based diagnostic lab advancing women’s health through molecular innovation, today announced the national launch of EdenDx, which stands for Early Detection for Endometrial Neoplasia, the first commercially available non-invasive liquid-based cytology test in the United States for early-stage endometrial cancer detection.
In a study conducted in Uganda and published in JAMA Surgery, researchers from Karolinska Institutet evaluated a new surgical method for treating groin hernias in women. The method could become an alternative in resource-limited settings where laparoscopic techniques are not generally available.
ASPIVIX has announced a new partnership with AGHealth to launch Carevix, its MHRA-approved non-traumatic suction cervical stabiliser, in the United Kingdom. The company says this milestone marks a significant advance in UK women’s healthcare, offering a modern and clinically validated alternative to the traditional cervical tenaculum.
Camgenium, a leading medical device software company, has announced that its software product, ‘Reassure Pregnancy’, can improve outcomes for pregnant women at risk of pre-eclampsia through at-home monitoring.
A Caltech-led team has developed a safe, effective, and painless breast imaging technique that incorporates machine learning to help differentiate between suspicious and healthy tissue.
Inne, a healthtech startup empowering women to understand their reproductive health, has ‘broken through decades of stagnation’ in women’s health and become what it says is the first new tech-enabled contraception to receive certification in the UK and Europe with its Minilab saliva test device.
First-Ever Non-Surgical Permanent Birth Control System Gains CE Mark, Paving the Way for a New Era in Reproductive Health
Breakthrough Integrated Sacral Neuromodulation Device Approved to Treat Urinary Urge Incontinence with a Minimally Invasive, Patient-Centric Approach
Lilli Health, a company that coined the term Low Insulin Lifestyle [LILLI] created to help educate, treat and manage individuals with polycystic ovary syndrome (PCOS), has announced the launch of the Lilli App backed by decades of scientific research as the first-ever comprehensive platform focused on lowering insulin levels to reverse PCOS symptoms.